- Evidence of US Development and Testing of Airborne Ebola?!
by Robert Wenzel, Target Liberty, via http://www.lewrockwell.com/
It has been my contention that the recent Ebola outbreak is likely the result of US military testing of Ebola gone awry. SEE: THE PAPER TRAIL: The US Government Involvement in Developing Ebola as a BioWeapon
Now more evidence has been brought to my attention of the alarming nature of the Ebola testing going on by the US military. Apparently, the military has created an airborne version of Ebola and tested it on monkeys.
A paper written by E. Johnson, N. Jaax, J. White, and P. Jahrling of US Army Medical Research Institute of Infectious Diseases, Frederick, Maryland was published in 1995 in the International Journal of Experimental Pathology.
The abstract from the paper, Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus, informs:
The potential of aerogenic infection by Ebola virus was established by using a head-only exposure aerosol system. Virus-containing droplets of 0.8-1.2 microns were generated and administered into the respiratory tract of rhesus monkeys via inhalation. Inhalation of viral doses as low as 400 plaque-forming units of virus caused a rapidly fatal disease in 4-5 days. The illness was clinically identical to that reported for parenteral virus inoculation, except for the occurrence of subcutaneous and venipuncture site bleeding and serosanguineous nasal discharge. Immunocytochemistry revealed cell-associated Ebola virus antigens present in airway epithelium, alveolar pneumocytes, and macrophages in the lung and pulmonary lymph nodes; extracellular antigen was present on mucosal surfaces of the nose, oropharynx and airways. Aggregates of characteristic filamentous virus were present within type I pneumocytes, macrophages, and air spaces of the lung by electron microscopy. Demonstration of fatal aerosol transmission of this virus in monkeys reinforces the importance of taking appropriate precautions to prevent its potential aerosol transmission to humans.